![Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review - Clinical Therapeutics Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review - Clinical Therapeutics](https://www.clinicaltherapeutics.com/cms/asset/9aea5d9f-1c68-4bad-8222-94aa586f64ce/ga1.jpg)
Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review - Clinical Therapeutics
![Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network](https://www.grappanetwork.org/wp-content/uploads/2023/07/GRAPPA-Poster-A0-landscape-S.Lembke_v03-pdf.webp)
Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network
![Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015 - ACR Meeting Abstracts Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015 - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2015/09/Paper_54362_abstract_71746_0.jpg)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015 - ACR Meeting Abstracts
![Bimekizumab, a Humanized Monoclonal Immunoglobulin G1 Antibody for the Treatment of Psoriatic Arthritis: A Systematic Review - touchIMMUNOLOGY Bimekizumab, a Humanized Monoclonal Immunoglobulin G1 Antibody for the Treatment of Psoriatic Arthritis: A Systematic Review - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2023/06/TOUCHIMMUNOLOGY-D-23-00002-Tanaka-Fig-1.png)
Bimekizumab, a Humanized Monoclonal Immunoglobulin G1 Antibody for the Treatment of Psoriatic Arthritis: A Systematic Review - touchIMMUNOLOGY
![Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis](https://www.frontiersin.org/files/MyHome%20Article%20Library/723944/723944_Thumb_400.jpg)
Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
![EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update | Annals of the Rheumatic Diseases EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/6/700.1/F1.large.jpg)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update | Annals of the Rheumatic Diseases
![Application of the GRAPPA Psoriatic Arthritis Treatment Recommendations in Clinical Practice | SpringerLink Application of the GRAPPA Psoriatic Arthritis Treatment Recommendations in Clinical Practice | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11926-010-0109-y/MediaObjects/11926_2010_109_Fig1_HTML.gif)
Application of the GRAPPA Psoriatic Arthritis Treatment Recommendations in Clinical Practice | SpringerLink
![Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data - The Lancet Regional Health – Europe Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/asset/8e9d6287-90de-44a2-840e-25685fbdc0ed/gr1.jpg)
Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data - The Lancet Regional Health – Europe
![Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41584-022-00798-0/MediaObjects/41584_2022_798_Fig1_HTML.png)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology
![European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | Annals of the Rheumatic Diseases European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/71/1/4/F1.large.jpg)
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | Annals of the Rheumatic Diseases
![Bimekizumab approved by MHRA for psoriatic arthritis and axial spondyloarthritis - Hospital Pharmacy EuropeHospital Pharmacy Europe Bimekizumab approved by MHRA for psoriatic arthritis and axial spondyloarthritis - Hospital Pharmacy EuropeHospital Pharmacy Europe](https://hospitalpharmacyeurope.com/wp-content/uploads/2023/08/Bimekizumab_approved_by_MHRA_for_psoriatic_arthritis_and_axial_spondyloarthritis.jpg)
Bimekizumab approved by MHRA for psoriatic arthritis and axial spondyloarthritis - Hospital Pharmacy EuropeHospital Pharmacy Europe
![Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome](https://www.frontiersin.org/files/Articles/662047/fmolb-08-662047-HTML/image_m/fmolb-08-662047-g001.jpg)